Tom Powles: The FDA Approval of Perioperative EVP in Bladder Cancer is a Landmark Moment

Tom Powles, Head of Solid Tumor Research at Barts Cancer Institute, shared a post on X: “The FDA approval of perioperative EVP in muscle invasive bladder cancer makes platinum eligable somewhat […]

Read the full article

2h agoen

cancer

You might also wanna read

<![CDATA[Pembrolizumab Plus EV Regimens Receive FDA Approval for Muscle Invasive Bladder Cancer]]>

Pharmacy Times·8h ago

<![CDATA[FDA OKs Pembrolizumab/EV Combo in Muscle Invasive Bladder Cancer]]>

CancerNetwork·9h ago

PTC-guided Neoadjuvant Therapy For Muscle-invasive Bladder Cancer

Conditions : Bladder Cancer Interventions : Drug: PTC guided individualized neoadjuvant therapy Sponsors : The Affiliated Nanjing Drum Tower

clinicaltrials.gov·3d ago

Antibody-Drug Conjugates in Perioperative Treatment of Muscle-Invasive Bladder Cancer: Expert Perspectives

Are your treatment plans for MIBC current? Learn about the latest guidelines for perioperative antibody-drug conjugate (ADC)-based combinati

mdsc.pe·10d ago

Real-World EV Plus Pembro Success Seen in Urothelial Cancer

A retrospective study evaluates outcomes associated with first-line enfortumab vedotin plus pembrolizumab vs gemcitabine plus cisplatin in p